Rise in Young Japanese Patients with Anorexia Nervosa Post-COVID-19

The COVID-19 pandemic has led to a notable increase in anorexia nervosa cases among young people in Japan, reversing previous declining trends. This rise highlights the need for targeted mental health interventions during societal crises.
A recent comprehensive study has highlighted a significant increase in the number of young individuals diagnosed with anorexia nervosa (ICD-10: F50.0) in Japan following the COVID-19 pandemic. Researchers analyzed large-scale clinical data and discovered that while the incidence of anorexia nervosa among youth was gradually decreasing prior to the pandemic, this trend reversed after the onset of COVID-19. The study, published in the journal Medicina on March 3, 2025, was led by Professor Takahiro Nemoto from Toho University’s Department of Psychiatry and Neuroscience.
The findings indicated a notable surge in cases among younger age groups, with an especially marked rise among males. This pattern aligns with observations from Western countries, where lifestyle changes driven by the pandemic have been linked to increases in eating disorders among young populations. The research also suggests that psychological factors and social relationships may serve as critical risk factors, emphasizing the need for tailored interventions to address these issues during public health crises.
The public health impact of these findings underscores the importance of implementing targeted support systems and preventive measures to mitigate the mental health effects of major societal disruptions like the COVID-19 pandemic. Understanding these trends is crucial for developing strategies to prevent the onset of anorexia nervosa and its social consequences among vulnerable youth in Japan and across Asia.
For more detailed information, see the original study by Yoshifumi Fukuya et al., published in Medicina: [DOI: 10.3390/medicina61030445].
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Combination Therapy Halves Recurrence and Mortality in Stage 3 Colon Cancer
New clinical research shows that adding immunotherapy to chemotherapy after surgery can reduce recurrence and death risk by 50% in stage 3 colon cancer patients, offering hope for more effective, personalized treatments.
Innovative Technique Enables Long-Term Brain Activity Monitoring in Freely Moving Mice
A novel method, CaliAli, enables researchers to monitor neuronal activity in freely moving mice continuously for over 99 days, advancing long-term brain research and understanding of neurological disorders.
Understanding Recurring Sinus Polyps and Effective Treatment Strategies
Recent research uncovers the cellular mechanisms behind persistent sinus polyps and highlights new targeted therapies, offering hope for better management of chronic rhinosinusitis. source: https://medicalxpress.com/news/2025-09-sinus-polyps-tackle.html
RFK Jr. Calls for Re-Evaluation of Mifepristone, the Common Abortion Pill
U.S. health officials are reviewing the safety of mifepristone, a widely used medication for early pregnancy termination, amid ongoing political and legal debates. Experts call for evidence-based evaluation of potential risks and adverse events.



